Substrate
finance

Anthropic Restricts Access to AI Models for Users in China

Wall Street employees based in Chinese territory have been unable to access AI models developed by Anthropic for several weeks. The restriction emerged prior to April 29, 2026, affecting financial professionals in the region. Details on the reasons or specific models impacted remain unspecified.

FI
1 source·Apr 29, 3:49 AM(7 days ago)·1m read
|
Anthropic Restricts Access to AI Models for Users in Chinathehindu.com
Audio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.

Wall Street employees located in Chinese territory were unable to access AI models developed by Anthropic as of a few weeks ago, @FirstSquawk reported. The restriction on access to Anthropic's AI models emerged several weeks prior to April 29, 2026. The situation impacts financial professionals operating in Chinese territory.

The report did not specify the reasons for the access issues or which specific AI models were affected. Further details on potential resolutions or broader implications were not provided.

Key Facts

Access restriction to Anthropic AI
Wall Street employees in Chinese territory unable to access AI models developed by Anthropic as of a few weeks ago.
Timing of restriction
The restriction emerged several weeks prior to April 29, 2026.
Impact on professionals
The situation impacts financial professionals operating in Chinese territory.

Story Timeline

3 events
  1. 2026-04-29

    Current date; restriction on Anthropic AI access has been in place for several weeks prior.

    1 source@FirstSquawk
  2. Several weeks prior to 2026-04-29

    Restriction on access to Anthropic's AI models emerged, affecting Wall Street employees in Chinese territory.

    1 source@FirstSquawk
  3. A few weeks ago (relative to 2026-04-29)

    Wall Street employees in Chinese territory became unable to access Anthropic AI models.

    1 source@FirstSquawk

Potential Impact

  1. 01

    Potential disruption to financial operations relying on AI tools in China.

  2. 02

    Possible shift to alternative AI providers for Wall Street firms in the region.

  3. 03

    Broader implications for AI accessibility in Chinese territory.

Transparency Panel

Sources cross-referenced1
Framing risk0/100 (low)
Confidence score65%
Synthesized bySubstrate AI
Word count78 words
PublishedApr 29, 2026, 3:49 AM
Bias signals removed2 across 2 outlets
Signal Breakdown
neutral omission 2

Related Stories

Oil Prices Drop After Reports of U.S.-Iran Talks on Ending War and Reopening Strait of HormuzJashuah / Wikimedia (CC BY-SA 3.0)
finance2 hrs ago

Oil Prices Drop After Reports of U.S.-Iran Talks on Ending War and Reopening Strait of Hormuz

Oil prices dropped significantly following reports that the U.S. and Iran are close to a memorandum of understanding to halt fighting and begin nuclear talks. President Trump announced a pause in the U.S. naval escort operation in the Strait of Hormuz. Iran is expected to respond…

cnbc.com
DE
UN
3 sources
Crypto Firm World Liberty Financial Sues Investor Justin Sun Over Alleged Smear Campaigninsidermonkey.com
finance2 hrs agoDeveloping

Crypto Firm World Liberty Financial Sues Investor Justin Sun Over Alleged Smear Campaign

World Liberty Financial, a cryptocurrency company founded by the Trump and Witkoff families, has filed a lawsuit accusing investor Justin Sun of conducting a smear campaign to harm its token's value. The suit claims Sun shorted the token in violation of agreements and used social…

Fox News
1 source
FDA Withdraws Studies Supporting Safety of COVID and Shingles VaccinesThe U.S. Food and Drug Administration / Wikimedia (Public domain)
finance2 hrs ago

FDA Withdraws Studies Supporting Safety of COVID and Shingles Vaccines

The U.S. Food and Drug Administration blocked the publication of research finding rare side effects from COVID and shingles vaccines. The studies were withdrawn due to broad conclusions not supported by data, amid broader efforts by the Trump administration to challenge vaccine r…

cnbc.com
The New York Times
Forbes
3 sources